Consultant in Emerging Health Technologies

Susan Morgensztern

Susan Morgensztern is a biotech leader with over 35 years of experience as a strategic development consultant for new technologies and markets to biotechnology, medical device and diagnostic firms.

She serves on the Advisory Board of the UW School of Public Health and the University of Massachusetts Institute for Diversity Sciences. Previously co-chaired Technology Screening Committee of WINGS Angel Network, Board Chair of Seattle BioMed, and  Expert Reviewer for the Life Science Discovery Fund.